• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

β-内酰胺类与氨基糖苷类联合用药对多重耐药铜绿假单胞菌和鲍曼不动杆菌的体外杀菌作用

In vitro bactericidal effect of a beta-lactam+aminoglycoside combination against multiresistant Pseudomonas aeruginosa and Acinetobacter baumannii.

作者信息

Roussel-Delvallez M, Wallet F, Delpierre F, Courcol R J

机构信息

Laboratoire de Bactériologie-Hygiène, Hôpital A. Calmette, Lille, France.

出版信息

J Chemother. 1996 Oct;8(5):365-8. doi: 10.1179/joc.1996.8.5.365.

DOI:10.1179/joc.1996.8.5.365
PMID:8957716
Abstract

Pseudomonas aeruginosa and Acinetobacter baumannii are frequently isolated in hospital outbreaks of nosocomial infections. In our hospital, among 1018 strains isolated one year in an intensive care unit, 84 strains (8.3%) of P. aeruginosa and 155 strains (15.2%) of A. baumannii were considered responsible for infections. The major problem related to these bacteria is their multiresistant characteristic which confers great difficulty in treating infections. We carried out a 24 h time-kill study to assess the bactericidal effect of three beta-lactams [imipenem (IPM), ticarcillin+clavulanic acid (TCC), piperacillin+tazobactam (PTB)] in combination with each other and with sulbactam (SUL) and amikacin (AKN) against 8 P. aeruginosa strains and 8 A. baumannii strains. The initial inoculum was 10(6) cfu/ml. Antibiotics were tested at clinically achievable concentrations: TCC (112 mg/l), PTB (100 mg/l), IPM (25 mg/l) and AKN (15 mg/l). The results showed: IMP + TCC + AKN = PTB + SUL + AKN = PTB + TCC + AKN > > IMP + SUL + AKN against P. aeruginosa; and PTB + SUL + AKN = PTB + TCC + AKN > IMP + SUL + AKN or IMP + TCC + AKN against A. baumannii. When infection due to these multiresistant strains was suspected, PTB + AKN combined with either TCC or SUL was bactericidal against both strains. These combinations appeared to be an alternative therapy in the treatment of undocumented nosocomial infections in intensive care units. These in vitro results are being evaluated in patients and seem to give good results for the moment.

摘要

铜绿假单胞菌和鲍曼不动杆菌在医院医院感染暴发中经常被分离出来。在我们医院,某一年在重症监护病房分离出的1018株菌株中,84株(8.3%)铜绿假单胞菌和155株(15.2%)鲍曼不动杆菌被认为是感染的致病菌。与这些细菌相关的主要问题是它们的多重耐药特性,这给感染治疗带来了很大困难。我们进行了一项24小时的时间杀菌研究,以评估三种β-内酰胺类药物[亚胺培南(IPM)、替卡西林+克拉维酸(TCC)、哌拉西林+他唑巴坦(PTB)]相互联合以及与舒巴坦(SUL)和阿米卡星(AKN)联合对8株铜绿假单胞菌菌株和8株鲍曼不动杆菌菌株的杀菌效果。初始接种量为10(6) cfu/ml。抗生素在临床可达到的浓度下进行测试:TCC(112 mg/l)、PTB(100 mg/l)、IPM(25 mg/l)和AKN(15 mg/l)。结果显示:对于铜绿假单胞菌,IMP + TCC + AKN = PTB + SUL + AKN = PTB + TCC + AKN >> IMP + SUL + AKN;对于鲍曼不动杆菌,PTB + SUL + AKN = PTB + TCC + AKN > IMP + SUL + AKN或IMP + TCC + AKN。当怀疑是由这些多重耐药菌株引起的感染时,PTB + AKN联合TCC或SUL对两种菌株均有杀菌作用。这些联合用药似乎是治疗重症监护病房不明医院感染的一种替代疗法。这些体外研究结果正在患者中进行评估,目前似乎取得了良好的效果。

相似文献

1
In vitro bactericidal effect of a beta-lactam+aminoglycoside combination against multiresistant Pseudomonas aeruginosa and Acinetobacter baumannii.β-内酰胺类与氨基糖苷类联合用药对多重耐药铜绿假单胞菌和鲍曼不动杆菌的体外杀菌作用
J Chemother. 1996 Oct;8(5):365-8. doi: 10.1179/joc.1996.8.5.365.
2
In vitro activity of beta-lactam antimicrobial agents in combination with aztreonam tested against metallo-beta-lactamase-producing Pseudomonas aeruginosa and Acinetobacter baumannii.β-内酰胺类抗菌药物与氨曲南联合对产金属β-内酰胺酶的铜绿假单胞菌和鲍曼不动杆菌的体外活性。
J Chemother. 2005 Dec;17(6):622-7. doi: 10.1179/joc.2005.17.6.622.
3
Bactericidal in-vitro activity of beta-lactams and beta-lactamase inhibitors, alone or associated, against clinical strains of Acinetobacter baumannii: effect of combination with aminoglycosides.β-内酰胺类药物和β-内酰胺酶抑制剂单独或联合使用对鲍曼不动杆菌临床菌株的体外杀菌活性:与氨基糖苷类药物联合使用的效果
J Antimicrob Chemother. 1995 Oct;36(4):619-29. doi: 10.1093/jac/36.4.619.
4
[Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].[对从重症监护病房和住院诊所患者中分离出的铜绿假单胞菌和鲍曼不动杆菌菌株的抗生素敏感性率进行四年监测]
Mikrobiyol Bul. 2008 Apr;42(2):321-9.
5
Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.β-内酰胺类与β-内酰胺酶抑制剂三种组合(哌拉西林/他唑巴坦、替卡西林/克拉维酸和氨苄西林/舒巴坦)体外活性的比较评价
Braz J Infect Dis. 2000 Feb;4(1):22-8.
6
[Value of bactericidal curves in the optimal selection of a beta-lactam-aminoglycoside combination on Pseudomonas aeruginosa. In vitro study of 40 strains of Pseudomonas aeruginosa isolated in pediatric intensive care units].[杀菌曲线在优化选择β-内酰胺类抗生素与氨基糖苷类抗生素联合治疗铜绿假单胞菌中的价值。对儿科重症监护病房分离出的40株铜绿假单胞菌进行的体外研究]
Presse Med. 1986 Dec 20;15(46):2309-12.
7
[In vitro activity of beta-lactam agents and beta-lactamase inhibitors in clinical isolates of Acinetobacter baumannii].[鲍曼不动杆菌临床分离株中β-内酰胺类药物和β-内酰胺酶抑制剂的体外活性]
Rev Esp Quimioter. 1999 Jun;12(2):140-3.
8
In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.非传统抗菌药物单独或联合使用对从重症监护病房分离出的多重耐药铜绿假单胞菌和鲍曼不动杆菌菌株的体外活性。
Int J Antimicrob Agents. 2006 Mar;27(3):224-8. doi: 10.1016/j.ijantimicag.2005.10.012. Epub 2006 Feb 7.
9
Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics.基于药代动力学/药效学的重症监护病房革兰氏阴性菌肺部感染β-内酰胺类治疗方案比较
J Antimicrob Chemother. 2005 Nov;56(5):893-8. doi: 10.1093/jac/dki335. Epub 2005 Sep 14.
10
[E-test to study small inhibitor concentrations, bacterial diversity and to identify presumptively beta-lactamases in strains of Pseudomonas aeruginosa and Acinetobacter baumannii associated with +nosocomial infections].[采用E试验研究与医院感染相关的铜绿假单胞菌和鲍曼不动杆菌菌株中的小抑制剂浓度、细菌多样性并初步鉴定β-内酰胺酶]
Rev Med Chil. 1997 Feb;125(2):149-60.

引用本文的文献

1
In search for a synergistic combination against pandrug-resistant A. baumannii; methodological considerations.针对泛耐药鲍曼不动杆菌的协同组合的寻找:方法学考虑。
Infection. 2022 Jun;50(3):569-581. doi: 10.1007/s15010-021-01748-w. Epub 2022 Jan 4.
2
Systematic Review of Antimicrobial Combination Options for Pandrug-Resistant .泛耐药菌抗菌联合治疗方案的系统评价
Antibiotics (Basel). 2021 Nov 3;10(11):1344. doi: 10.3390/antibiotics10111344.
3
Novel approach to optimize synergistic carbapenem-aminoglycoside combinations against carbapenem-resistant Acinetobacter baumannii.
优化碳青霉烯类抗生素与氨基糖苷类抗生素联合使用以对抗耐碳青霉烯鲍曼不动杆菌的新方法。
Antimicrob Agents Chemother. 2015 Apr;59(4):2286-98. doi: 10.1128/AAC.04379-14. Epub 2015 Feb 2.
4
Acinetobacter baumannii: emergence of a successful pathogen.鲍曼不动杆菌:一种成功病原体的出现
Clin Microbiol Rev. 2008 Jul;21(3):538-82. doi: 10.1128/CMR.00058-07.